# Kuvatris Therapeutics, Inc.

Kuvatris Therapeutics, Inc. is a company headquartered in Tarrytown, NY, United States.

## Company overview

- **Legal name:** Kuvatris Therapeutics, Inc.
- **Former names in filing history:** PaxMedica, Inc. (2020-05-15 to 2025-06-13)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Tarrytown, NY, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001811623

## About

Kuvatris Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001811623, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-11, it reported annual revenue of USD 0; net income of USD -18,289,725; total assets of USD 5,680,405 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$18.3M (USD -18,289,725)
- **Total assets:** $5.7M (USD 5,680,405)
- **Operating cash flow:** -$10.8M (USD -10,768,504)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$14.8M (USD -14,801,767)
- **Total assets:** $2.2M (USD 2,204,318)
- **Cash and equivalents:** $1.9M (USD 1,901,887)
- **Operating cash flow:** -$6.1M (USD -6,071,183)

## Recent SEC filings

- Form 10-Q — filed 2026-01-14 — period 2024-09-30 — 10-Q
- Form 8-K — filed 2025-06-13 — period 2025-06-06 — 8-K
- Form 8-K — filed 2025-04-04 — period 2025-04-02
- Form 8-K — filed 2025-03-07 — period 2025-02-28
- Form 8-K — filed 2025-02-06 — period 2025-01-31
- Form S-1 — filed 2024-10-03
- Form 10-Q — filed 2024-09-20 — period 2024-06-30 — 10-Q
- Form 8-K — filed 2024-09-06 — period 2024-09-03
- Form 8-K — filed 2024-07-19 — period 2024-07-16
- Form 8-K — filed 2024-06-14 — period 2024-06-10 — FORM 8-K
- Form 8-K — filed 2024-05-28 — period 2024-05-23 — FORM 8-K
- Form 8-K — filed 2024-05-15 — period 2024-05-15 — FORM 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/kuvatris-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology